Antibacterial and antifungal action of CTAB-containing silica nanoparticles against human pathogens.
Pedro Martins da Silva Filho, Pedro Higor Rocha Mariano, Alexandre Lopes Andrade, Jessica Barros Arrais Cruz Lopes, Aryane de Azevedo Pinheiro, Mayara Itala Geronimo de Azevedo, Suelen Carneiro de Medeiros, Mayron Alves de Vasconcelos, Said Gonçalvez da Cruz Fonseca, Thalles Barbosa Grangeiro, Luiz Gonzaga de França Lopes, Eduardo Henrique Silva Sousa, Edson Holanda Teixeira, Elisane Longhinotti
International journal of pharmaceutics 2023 Jun 25New antibiotic agents are urgently needed worldwide to combat the increasing tolerance and resistance of pathogenic fungi and bacteria to current antimicrobials. Here, we looked at the antibacterial and antifungal effects of minor quantities of cetyltrimethylammonium bromide (CTAB), ca. 93.8 mg g-1, on silica nanoparticles (MPSi-CTAB). Our results show that MPSi-CTAB exhibits antimicrobial activity against Methicillin-resistant Staphylococcus aureus strain (S. aureus ATCC 700698) with MIC and MBC of 0.625 mg mL-1 and 1.25 mg mL-1, respectively. Additionally, for Staphylococcus epidermidis ATCC 35984, MPSi-CTAB reduces MIC and MBC by 99.99% of viable cells on the biofilm. Furthermore, when combined with ampicillin or tetracycline, MPSi-CTAB exhibits reduced MIC values by 32- and 16-folds, respectively. MPSi-CTAB also exhibited in vitro antifungal activity against reference strains of Candida, with MIC values ranging from 0.0625 to 0.5 mg mL-1. This nanomaterial has low cytotoxicity in human fibroblasts, where over 80% of cells remained viable at 0.31 mg mL-1 of MPSi-CTAB. Finally, we developed a gel formulation of MPSi-CTAB, which inhibited in vitro the growth of Staphylococcus and Candida strains. Overall, these results support the efficacy of MPSi-CTAB with potential application in the treatment and/or prevention of infections caused by methicillin-resistant Staphylococcus and/or Candida species. Copyright © 2023. Published by Elsevier B.V.
Citation
Pedro Martins da Silva Filho, Pedro Higor Rocha Mariano, Alexandre Lopes Andrade, Jessica Barros Arrais Cruz Lopes, Aryane de Azevedo Pinheiro, Mayara Itala Geronimo de Azevedo, Suelen Carneiro de Medeiros, Mayron Alves de Vasconcelos, Said Gonçalvez da Cruz Fonseca, Thalles Barbosa Grangeiro, Luiz Gonzaga de França Lopes, Eduardo Henrique Silva Sousa, Edson Holanda Teixeira, Elisane Longhinotti. Antibacterial and antifungal action of CTAB-containing silica nanoparticles against human pathogens. International journal of pharmaceutics. 2023 Jun 25;641:123074
Mesh Tags
Substances
PMID: 37230370
View Full Text
